Carbohydrate chain terminators: Rational design of novel carbohydrate-based antifungal agents

ChemBioChem

Volumn 8, Issue 11, 2007, Pages 1241-1245

  Danac, Ramona ^a   Ball, Lucy ^a   Gurr, Sarah J ^a   Muller, Thierry ^a   Fairbanks, Antony J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antifungal agents; Biosynthesis; Carbohydrates; Chain termination; Oligosaccharides

Indexed keywords

ANTIFUNGAL AGENT; AZIDOOXAZOLINE; CARBOHYDRATE; CHITIN; CHITIN SYNTHASE; FLUOROOXAZOLINE; OXAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG DESIGN; DRUG STABILITY; DRUG SYNTHESIS; GERMINATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CARBOHYDRATES; DRUG DESIGN; MITOCHONDRIA; MOLECULAR STRUCTURE; TRICHOPHYTON;

EID: 34547471108     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.200700234     Document Type: Article

References (35)

1. a) N. Asano, Glycobiology 2003, 13, 93R-104R;
2. b) P. Sears, C.-H. Wong, Angew. Chem. 1999, 111, 2446-2471;
3. Angew. Chem. Int. Ed. 1999, 38, 2300-2324.
4. C. R. Bertozzi, L. L. Kiessling, Science 2001, 291, 2357-2364.
5. F. Sanger, S. Nicklen, A. R. Coulson, Proc. Natl. Acad. Sci. USA 1977, 74, 5463-5467.
6. R. S. Goody, B. Müller, T. Restle, FEBS Lett. 1991, 291, 1-5.
7. a) C. J. Dimitroff, R. J. Bernacki, R. Sackstein, Blood 2003, 101, 602-610;
8. b) B. Woynarowska, C. J. Dimitroff, M. Sharma, K. L. Matta, R. J. Bernacki, Glycoconjugate J. 1996, 13, 663-674;
9. c) B. Woynarowska, D. M. Skrincosky, A. Haag, M. Sharma, K. L. Matta, R. J. Bernacki, J. Biol. Chem. 1994, 269, 22797-22803;
10. d) R. J. Bernacki, W. Korytnyk in The Glycoconjugates, Vol. 4 (Ed.: M. I. Horowitz), Academic, New York, 1982, pp. 245-263.
11. a) A. Berkin, W. A. Szarek, R. Kisilevsky, Glycoconjugate J. 2005, 22, 443-451;
12. b) R. Kisilevsky, W. A. Szarek, J. B. Ancsin, E. Elimova, S. Marone, S. Bhat, A. Berkin, Am. J. Pathol. 2004, 164, 2127-2137;
13. c) A. Berkin, W. A. Szarek, R. Kisilevsky, Carbohydr. Res. 2002, 337, 37-44;
14. d) S. S. Thomas, J. Plenkiewicz, E. R. Ison, M. Bols, W. Zou, W. A. Szarek, R. Kisilevsky, Biochim. Biophys. Acta 1995, 1272, 37-48.
15. See for example: a) K. Sujino, T. Uchiyama, O. Hindsgaul, N. O. L. Seto, W. W. Wakarchuk, M. M. Palcic, J. Am. Chem. Soc. 2000, 122, 1261-1269;
16. b) Y. Kajihara, T. Endo, H. Ogasawara, H. Kodama, H. Hashimoto, Carbohydr. Res. 1995, 269, 273-294;
17. c) G. Srivastava, O. Hindsgaul, M. M. Palcic, Carbohydr. Res. 1993, 245, 137-144.
18. There are more than 50 examples of modified donors that act as substrates for glycosyl transferases. For a review see: X. Qian, K. Sujino, M. M. Palcic, in Carbohydrates in Chemistry and Biology, Vol. 2 (Eds.: B. Ernst, G. W. Hart, P. Sinay) Wiley-VCH, Weinheim, 2000, pp. 685-703,.
19. M. Nucci, K. A. Marr, Emerging Infect. 2005, 41, 521-526.
20. H. Vanden Bossche, P. Marichal, F. C. Odds, Trends Microbiol. 1994, 2, 393-400.
21. S. M. Bowman, S. J. Free, BioEssays 2006, 28, 799-808.
22. N. H. Georgopapadakou, J. S. Tkacz, Trends Microbiol. 1995, 3, 98-104.
23. C. A. Munro, N. A. R. Gow, Med. Mycol. 2001, 39, 41-53.
24. For a similar, recently published approach that demonstrates that a UDP-GlcNAc derivative, in which the 4-hydroxyl is methylated, is a substrate for chitin synthase see: R. Chang, P. Moquist, N. S. Finney, Carbohydr. Res. 2004, 339, 1531-1536.
25. See ref. [14]; in addition, full details of the synthesis and biological activity of the corresponding 4-methoxy, 4-fluoro, 4-deoxy and 4-azido UDP-GlcNAc derivatives and their precursors will be reported in due course.
26. a) T. W. D. F. Rising, T. D. W. Claridge, J. W. B. Moir, A. J. Fairbanks, ChemBioChem 2006, 7, 1177-1180;
27. b) T. W. D. F. Rising, T. D. W. Claridge, N. Davies, D. P. Gamblin, J. W. B. Moir, A. J. Fairbanks, Carbohydr. Res. 2006, 341, 1574-1596.
28. D. H. R. Barton, S. W. McCombie, J. Chem. Soc. Perkin Trans. 1 1975, 1574-1585.
29. Attempts at triflation led to the formation of tetrazole side products through reaction of the NHAc group at C-2, whilst the corresponding mesylate was too unreactive to undergo efficient displacement by azide.
30. J. Fiandor, M. T. Garcia-Lopez, F. G. DeLas Heras, P. P. Mendez-Castrillon, Synthesis 1985, 1121-1123.
31. S. Kobayashi, T. Kiyosada, S. Shoda, Tetrahedron Lett. 1997, 38, 2111-2112.
32. I. Weitzman, R. C. Summerbell, Clin. Microbiol. Rev. 1995, 8, 240-259.
33. See the Supporting Information for details of these assays together with full experimental and spectroscopic data for the synthesis of all new compounds.
34. For example: fluoride oxazoline diol (24), ClogP = -0.53; fluoride oxazoline dibenzoate (20) Clog P = 4.73.
35. In fact, a combination of both chain termination itself and enzyme inhibition by chain-terminated products might contribute to the observed bioactivity - much the same as reverse transcriptase inhibition by chain-terminating oligonucleotides.